Dietary polyphenols and metabolic syndrome among Iranian adults

References

• Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brein WL, et al. 2000. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, et al. 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645
   PubMed Web of Science ®Google Scholar
• Almoosawi S, Tsang C, Ostertag LM, Fyfe L, Al-Dujaili EA. 2012. Differential effect of polyphenol-rich dark chocolate on biomarkers of glucose metabolism and cardiovascular risk factors in healthy, overweight and obese subjects: a randomized clinical trial. Food Funct 3:1035–1043
   PubMed Web of Science ®Google Scholar
• Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, et al. 2009. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 10:1--15
   PubMedGoogle Scholar
• Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B, et al. 2010. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med 13:426–428
   PubMed Web of Science ®Google Scholar
• Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, Ghanbili J, et al. 2002. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed 47:408–426
   PubMedGoogle Scholar
• Barona J, Aristizabal JC, Blesso CN, Volek JS, Fernandez ML. 2012. Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. J Nutr 142:1626–1632
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Bush TL. 1991. Estrogen and coronary heart disease in women. JAMA 265:1861–1867
   PubMed Web of Science ®Google Scholar
• Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS. 2008. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 138:1677–1683
   PubMed Web of Science ®Google Scholar
• Djousse L, Padilla H, Nelson TL, Gaziano JM, Mukamal KJ. 2010. Diet and metabolic syndrome. Endocr Metab Immune Disord Deug Targets 10:124–137
   PubMedGoogle Scholar
• Dupasquier CMC, Dibrov E, Kneesh AL, Cheung PK, Lee KG, Alexander HK, Yeganeh BK, et al. 2007. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am J of Physiol Heart Circ Physiol 293:H2394–H2402
   PubMed Web of Science ®Google Scholar
• Dupasquier CMC, Weber AM, Ander BP, Rampersad PP, Steigerwald S, Wigle JT, Mitchell RW, et al. 2006. Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. Am J Physiol Heart Circ Physiol 291:H2987–H2996
   PubMed Web of Science ®Google Scholar
• Egert S, Bosy-Westphal A, Seiberl J, Kürbitz C, Settler U, Plachta-Danielzik S, Wagner AE, et al. 2009. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 102:1065–1074
   PubMed Web of Science ®Google Scholar
• Ford ES. 2005. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28:1769–1778
   PubMed Web of Science ®Google Scholar
• Ghafarpour M, Houshiar-Rad A, Kianfar H. 1999. The manual for household measures, cooking yields factors and edible portion of food. Tehran: Keshavarzi Press
   Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, et al. 2005. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752
   PubMed Web of Science ®Google Scholar
• Henriksen EJ, Diamond-Stanic MK, Marchionne EM. 2011. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 51:993–999
   PubMed Web of Science ®Google Scholar
• Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, Cassidy A. 2012. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr 95:740–751
   PubMed Web of Science ®Google Scholar
• Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, et al. 2008. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88:38–50
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP. 2007. The prevalence of metabolic syndrome in various populations. Am J Med Sci 333:362–371
   PubMed Web of Science ®Google Scholar
• Kriska AM, Knowler WC, LaPorte RE, Drash AL, Wing RR, Blair SN, Bennett PH, Kuller LH. 1990. Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 13:401–411
   PubMed Web of Science ®Google Scholar
• Kuijsten A, Bueno-de-Mesquita HB, Boer J, Arts IC, Kok FJ, van't Veer P, Hollman PC. 2009. Plasma enterolignans are not associated with nonfatal myocardial infarction risk. Atherosclerosis 203:145–152
   PubMed Web of Science ®Google Scholar
• Lambert JD, Sang S, Yang CS. 2007. Possible controversy over dietary polyphenols: benefits vs risks. Chem Res Toxicol 20:583–585
   PubMed Web of Science ®Google Scholar
• Lampe J, Martini M, Kurzer M, Adlercreutz H, Slavin J. 1994. Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr 60:122–128
   PubMed Web of Science ®Google Scholar
• Landete JM. 2012. Plant and mammalian lignans: a review of source, intake, metabolism, intestinal bacteria and health. Food Res Int 46:410--424
   Google Scholar
• Li C, Ford ES, Li B, Giles WH, Liu S. 2010. Association of testosterone and sex hormone–binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care 33:1618–1624
   PubMed Web of Science ®Google Scholar
• Lin J, Rexrode KM, Hu F, Albert CM, Chae CU, Rimm EB, Stampfer MJ, et al. 2007. Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am J Epidemiol 165:1305–1313
   PubMed Web of Science ®Google Scholar
• McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. 2012. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 95:454–464
   PubMed Web of Science ®Google Scholar
• Mennen LI, Sapinho D, de Bree A, Arnault N, Bertrais S, Galan P, Hercberg S. 2004. Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J Nutr 134:923–926
   PubMed Web of Science ®Google Scholar
• Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR Jr. 2007. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 85:895–909
   PubMed Web of Science ®Google Scholar
• Mirmiran P, Hosseini-Esfahani F, Mehrabi Y, Hedayati M, Azizi F. 2009. Reliability and relative validity of an FFQ for nutrients in the Tehran Lipid and Glucose Study. Public Health Nutr 13:645–662
   Google Scholar
• Morisset AS, Lemieux S, Veilleux A, Bergeron J, John Weisnagel S, Tchernof A. 2009. Impact of a lignan-rich diet on adiposity and insulin sensitivity in post-menopausal women. Br J Nutr 102:195–200
   PubMed Web of Science ®Google Scholar
• Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, et al. 2010. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56:1113–1132
   PubMed Web of Science ®Google Scholar
• Mursu J, Voutilainen S, Nurmi T, Tuomainen TP, Kurl S, Salonen JT. 2008. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr 100:890–895
   PubMed Web of Science ®Google Scholar
• Niemeyer HB, Metzler M. 2002. Oxidative metabolites and genotoxic potential of mammalian and plant lignans in vitro. J Chromatogr B Analyt Biomed Life Sci 777:321–327
   PubMed Web of Science ®Google Scholar
• Nurmi T, Mursu J, Pe ñalvo JL, Poulsen HE, Voutilainen S. 2010. Dietary intake and urinary excretion of lignans in Finnish men. Br J Nutr 103:677–685
   PubMed Web of Science ®Google Scholar
• Otsuka R, Imai T, Kato Y, Ando F, Shimokata H. 2010. Relationship between number of metabolic syndrome components and dietary factors in middle-aged and elderly Japanese subjects. Hypertens Res 33:548–554
   PubMedGoogle Scholar
• Perez-Jimenez J, Neveu V, Vos F, Scalbert A. 2010. Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: an application of the Phenol-Explorer database. J Agric Food Chem 58:4959–4969
   PubMed Web of Science ®Google Scholar
• Pfeuffer M, Auinger A, Bley U, Kraus-Stojanowic I, Laue C, Winkler P, Rufer CE, et al. 2011. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammatory parameters in men with different APOE isoforms. Nutr Metab Cardiovasc Dis [in press]
   Google Scholar
• Pietinen P, Rimm EB, Korhonen P, Hartman AM, Willett WC, Albanes D, Virtamo J. 1996. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Circulation 94:2720–2727
   PubMed Web of Science ®Google Scholar
• Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, et al. 2007. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292:E1378–E1387
   PubMed Web of Science ®Google Scholar
• Raffaelli B, Hoikkala A, Leppälä E, Wähälä K. 2002. Enterolignans. J Chromatogr B Analyt Technol Biomed Life Sci 777:29–43
   PubMed Web of Science ®Google Scholar
• Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. 1996. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 125:384–389
   PubMed Web of Science ®Google Scholar
• Schwandt A, Garcia JA. 2009. Complications of androgen deprivation therapy in prostate cancer. Curr Opin Urol 19:322–326
   PubMed Web of Science ®Google Scholar
• Spencer JPE, Abd El Mohsen MM, Minihane AM, Mathers JC. 2008. Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr 99:12–22
   PubMed Web of Science ®Google Scholar
• Steffen Y, Gruber C, Schewe T, Sies H. 2008. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys 469:209–219
   PubMed Web of Science ®Google Scholar
• Tavani A, Spertini L, Bosetti C, Parpinel M, Gnagnarella P, Bravi F, Peterson J, et al. 2006. Intake of specific flavonoids and risk of acute myocardial infarction in Italy. Public Health Nutr 9:369–374
   PubMed Web of Science ®Google Scholar
• Tomás-Barberán F, Andrés-Lacueva C. 2012. Polyphenols and health: current state and progress. J Agric and Food Chem 60:8773--8775
   Google Scholar
• USDA. Nutrient Data Laboratory. 2009. USDA database for the flavonoid content of selected foods. Release 2.1. 2007. Available at: http://www.ars.usda.gov/nutrientdata. Accessed on 9 March 2009
   Google Scholar
• Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H, Salonen JT. 1999. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet 354:2112–2115
   PubMed Web of Science ®Google Scholar
• Willett W, Stampfer M. 1998. Implications of total energy intake for epidemiological analysis. In: Willett W. Nutritional epidemiology. New York (NY): Oxford University Press. p. 273–301
   Google Scholar
• Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C, Weber P. 2006. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 136:2512–2518
   PubMed Web of Science ®Google Scholar
• Xiao ZP, Peng ZY, Peng MJ, Yan WB, Ouyang YZ, Zhu HL. 2011. Flavonoids health benefit and their molecular mechanism. Mini Rev Med Chem 11:169–177
   PubMed Web of Science ®Google Scholar